-
Crizonix (XALKORI) Crizotinib 250mg online
Crizonix (XALKORI) is a kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK) or ROS1-positive as detected by an FDA-approved test.
$498.00